文献速递关节外科创伤骨科骨质疏松与代谢性骨病

全膝关节置换术与假体周围股骨远端骨折:超越骨质疏松,关注既往骨质疏松性骨折

Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
PubMed 文献 · Osteoporos Int · 2024-05-27

本研究纳入34例初次全膝关节置换术(TKA)后假体周围骨折患者和106例年龄性别匹配的对照,评估骨质疏松与假体周围骨折的关联。骨折组骨质疏松患病率高于对照组(61.8% vs 40.6%,p=0.045),既往骨质疏松性骨折史(OR 9.1)和骨质疏松(OR 3.6)是显著危险因素,骨质疏松药物治疗可降低风险(OR 0.3)。

要点

  • TKA后假体周围骨折患者骨质疏松患病率高于对照(61.8% vs 40.6%,p=0.045)。
  • 既往骨质疏松性骨折史(OR 9.1)和骨质疏松(OR 3.6)是假体周围骨折的显著危险因素。
  • 骨质疏松药物治疗与假体周围骨折风险降低相关(OR 0.3,p=0.020)。

核心结论

  • 骨质疏松是TKA后假体周围股骨远端骨折的主要危险因素,尤其对于有骨质疏松性骨折史的患者。
  • 需要对骨质疏松进行仔细评估和适当治疗,并让初次TKA术后患者认识到服用骨质疏松药物的重要性。

研究设计与样本

  • 本研究为预后研究,证据等级III级。
  • 纳入34例初次TKA后假体周围骨折患者和106例年龄、性别匹配的对照。
  • 采用双能X线吸收法评估股骨颈、全髋和腰椎骨密度,并回顾医疗记录评估相关因素。
  • 使用单变量和多变量逻辑回归分析确定与假体周围骨折相关的因素。

主要发现

  • 骨折组骨质疏松患病率高于对照组(61.8% vs 40.6%,p=0.045)。
  • 骨折组骨质疏松药物治疗率显著低于对照组(47.6% vs 76.7%,p=0.026)。
  • 既往骨质疏松性骨折史(OR 9.1;p=0.015)和骨质疏松(OR 3.6;p=0.013)是TKA后假体周围骨折的显著危险因素。
  • 骨质疏松药物治疗可降低假体周围骨折风险(OR 0.3;p=0.020)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Osteoporosis increases the risk of periprosthetic distal femoral fractures after TKA, especially in patients with a history of osteoporotic fractures. Therefore, careful assessment and proper treatment of osteoporosis need and the importance of taking osteoporotic medication needs to be recognized by the patients following primary TKA. PURPOSE: Osteoporosis is a risk factor for fractures, including those of the hip, vertebrae, and distal radius; however, the association between osteoporosis and periprosthetic fractures after total knee arthroplasty (TKA) has not been much investigated. Therefore, we aimed to investigate the association of the presence of systemic osteoporosis with periprosthetic fractures after TKA. METHODS: This study included 34 patients with periprosthetic fractures following primary TKA and 106 controls matched for age and sex. Bone mineral density was evaluated at the femoral neck, total hip, and lumbar spine using dual X-ray absorptiometry. Medical records were reviewed for age; sex; body mass index; smoking; rheumatoid arthritis, endocrine diseases, and cardiovascular diseases; history of glucocorticoid use; medication for osteoporosis; and history of previous osteoporotic fracture. In addition, anterior femoral notching after TKA was evaluated. Univariable and multivariable logistic regression analysis were used to determine factors associated with periprosthetic fracture. RESULTS: The prevalence of osteoporosis in the fracture group was higher than that in the control group (61.8% vs. 40.6%, p=0.045). The rate of medication for osteoporosis was significantly low in the fracture group (47.6 % vs 76.7%, p=0.026). History of previous osteoporotic fracture (odds ratio [OR], 9.1; p=0.015) and osteoporosis (OR, 3.6; p=0.013) were significant risk factors for periprosthetic fractures after TKA. Medication for osteoporosis could decrease the risk of periprosthetic fracture (OR 0.3; p=0.020). CONCLUSION: Osteoporosis is a major risk factor for periprosthetic distal femoral fractures after TKA. Therefore, careful assessment and proper treatment of osteoporosis need and the importance of taking osteoporotic medication needs to be recognized to the patients following primary TKA, especially in patients with a history of osteoporotic fracture. LEVEL OF EVIDENCE: Prognostic study, level III.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Park YB, Kim M, Nam HC, et al. Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture. Osteoporos Int. 2024. PMID: 38801524. doi:10.1007/s00198-024-07138-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。